Skip to main content
PEN logo

PEN · Penumbra Inc · Metrics

Track PEN — free
$320.23 +1.12 (+0.35%) Q3 2025 earnings call transcript
Market Cap
$12.58B
Shares
39.41M
Volume · Nov 18 83.04K Avg daily vol (3M) 356.3K

PEN metrics

108 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$319.11
Market cap
$12.58B

Price action

23 metrics
Price change (1W)
-0.7%
Price change (30D)
-1.0%
Price change (3M)
-1.7%
Price change (6M)
-2.3%
Price change (YTD)
+2.6%
Price change (1Y)
+14.6%
Trailing year
Price change (5Y)
+19.7%
52-week high
$359.40
52-week low
$278.10
Change from 52-week high
-11.2%
Change from 52-week low
+14.7%
Annualized volatility
19.5%
Annualized volatility (3M)
7.9%
Implied volatility (30D)
20.8%
IV rank (1Y)
8.8
IV percentile (1Y)
33.8
Beta
0.2
RSI (14D)
44.8
Price vs SMA 50
-0.3%
Price vs SMA 200
-1.9%
Avg volume (3M)
356,297
Relative volume
1.0
Average dollar volume
$114.21M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
39.41M

Valuation

12 metrics
P / E (TTM)
80.4
Trailing earnings · reciprocal yield 1.2%
PEG ratio
—
EV / revenue
7.6×
reciprocal yield 13.1%
EV / EBITDA
57.0×
reciprocal yield 1.8%
EV / EBIT
63.0×
reciprocal yield 1.6%
P / sales
8.1×
reciprocal yield 12.4%
P / book
7.9
reciprocal yield 12.6%
FCF yield
1.6%
TTM · current market cap
Buyback yield
—
P / FCF
62.8
reciprocal yield 1.6%
P / operating cash flow
48.2
reciprocal yield 2.1%
Earnings yield
1.2%

Historical valuation

8 metrics
P / E historical average (3Y)
198.8×
reciprocal yield 0.5%
P / E historical average (5Y)
382.0×
reciprocal yield 0.3%
EV / revenue historical average (3Y)
7.6×
reciprocal yield 13.1%
EV / revenue historical average (5Y)
8.7×
reciprocal yield 11.5%
EV / EBIT historical average (3Y)
604.5×
reciprocal yield 0.2%
EV / EBIT historical average (5Y)
630.9×
reciprocal yield 0.2%
EV / EBITDA historical average (3Y)
167.8×
reciprocal yield 0.6%
EV / EBITDA historical average (5Y)
224.7×
reciprocal yield 0.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-29

Profitability

9 metrics
Gross margin
68.0%
Operating margin
12.1%
Trailing 12 months
Net margin
10.1%
Gross profit (TTM)
$1.06B
Operating profit (TTM)
$189.25M
Net income (TTM)
$157.02M
Trailing 12 months
Diluted EPS (TTM)
$3.97
FCF margin
12.8%
Effective tax rate
24.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$39.45
Gross profit per diluted share (TTM)
$26.82
Operating profit per diluted share (TTM)
$4.79
EBITDA per diluted share (TTM)
$5.29
Net income per diluted share (TTM)
$3.97
Operating cash flow per diluted share (TTM)
$6.60
Free cash flow per diluted share (TTM)
$5.07
Capital expenditures per diluted share (TTM)
$1.54
R&D per diluted share (TTM)
$2.40
Stock compensation per diluted share (TTM)
$1.48
Book value per share
$36.39

Growth

11 metrics
Revenue growth YoY
+15.6%
Year over year
Net income growth YoY
-7.8%
Revenue (TTM)
$1.56B
Trailing 12 months
EPS growth YoY
-8.5%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+18.3%
Revenue CAGR (5Y)
+20.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
9.9%
Return on assets
7.8%
Debt / equity
0.0
Current ratio
5.9
EBITDA (TTM)
$209.36M
Free cash flow (TTM)
$200.29M
Quick ratio
3.9
Interest coverage
149.6
Net debt / EBITDA
-1.1
Return on invested capital
10.6%
Trailing 12 months
Net cash
$232.88M
Latest balance sheet
Cash & equivalents
$254.28M
Total assets
$2.03B
Total debt
$21.41M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$261.05M
Capital expenditures (TTM)
$60.75M
R&D (TTM)
$94.93M
SG&A (TTM)
$776.61M
Stock compensation (TTM)
$58.40M
R&D / revenue
6.1%
Stock compensation / revenue
3.7%

Ownership (13F)

9 metrics
13F filers
432
13F filer change QoQ
-21
Institutional ownership
88.7%
Conviction holders (share of 13F filers)
6.5%
Crowding (high-turnover and private-fund holders)
38.2%
Private-fund adviser ownership
36.2%
Active holders' share change QoQ
+6.8%
Holder tenure
13.0
Price vs estimated holder cost
-1.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.3%

Short interest

3 metrics
Short interest
6.1%
Latest settlement · 5.3 days to cover
Days to cover
5.3d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1321732 CUSIP 70975L107 13F (30d) 445 filings 414 filers Visit website Investor relations